To test whether upregulation of ZFX could rescue these inhibitory effects, we re‐expressed either wide‐type (WT) or a codon‐optimized version mutant type (MT) of ZFX that was not targeted by shRNAs in shZFX‐infected HCC cell lines. This evidence concerns the gene ZFX and hepatocellular carcinoma.